Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06015815Completed
The Association of MicroRNA21-155 Levels With Acute Side Effects In Patients With Stage III NSCLC With Definitive CRT
Non-small Cell Lung Cancer Stage III
PrincipalinvestigatorStart date: 2019-10-05

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Ankara University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Carri Glide-Hurst, PhD, DABR, FAAPM

University of Wisconsin, Madison

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Michael Farris, MD

Wake Forest University Health Sciences

Moderately Similar
5 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Changli Wang

Tianjin Medical University Cancer Institute and Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Michael Farris, MD

Wake Forest Baptist Comprehensive Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Roberto Ferrara

Fondazione IRCCS ISTITUTO NAZIONALE TUMORI

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Alexander Chi, MD

Capital Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Kathleen Castro, R.N.

National Cancer Institute (NCI)

Moderately Similar
3 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Sung Yong Lee, MD, PhD

Korea University Guro Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Thomas Dilling, MD

Moffitt Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Valter Torri

Istituto Di Ricerche Farmacologiche Mario Negri

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Small Cell Lung Cancer (Stage III)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06015815PrincipalInvestigator

The Association of MicroRNA21-155 Levels With Acute Side Effects In Patients With Stage III NSCLC With Definitive CRT

Non-small Cell Lung Cancer Stage III
Completed

All 1 trials loaded